THE SOFIX HEALTH FEATURING A NOVEL PEPTIDE MIXTURE|

Recent data suggest The Sofix Health's Cagrilintide/GLP-1 represents a different therapeutic approach for targeting glucose-related illnesses. This peptide combination merges Cagrilintide, a selective GLP-1 receptor activator, with a conventional